|
|
|
 |
|
Kirit C. Patel M.D.,
F.A.C.C.
|
 |
 |
 |
43344
Woodward Avenue, Suite 111
Bloomfield Hills, MI 48302
tel: 248-333-1170
fax: 248-333-1175
map
this location
5701 Bow Pointe
Drive, Ste
205
Clarkston, MI
48346
Tel:
248-625-5550
Fax:
248-922-1551
map this
location
| |
|
|
|
Interventional Cardiology
Current and Past
Positions:
- Chief of Cardiology at St. Joseph Mercy Oakland.
- Chairman, Quality Assurance Committee in
Cardiology.
- Vice Chairman, Medical Records Committee.
- Member of the Credential and Qualification
Committee.
- Member of the Bylaws Committee.
- Board Member, OPNS.
- Representative at Large, Executive Committee, St.
Joseph Mercy Oakland.
Experience and
Training:
- 07/01/1985 - 06/30/1988- St. Joseph Mercy Oakland,
Pontiac, MI
Completed three years of Cardiology
Fellowship and an additional year of
Interventional/Angioplasty Fellowship in addition to
100 hours of nuclear cardiology training.
- 07/06/1982 - 06/30/1985- Rhode Island Hospital,
Providence, RI
Completed three years of residency
training in Internal Medicine
- Out of country- Regional Orthopedic Hospital,
Limerick, Ireland
Senior House Officer in
Orthopedic Surgery.
- Out of country- Government Wenlock Hospital &
Lady Goshen Hospital, Karnataka, India
Rotating
Internship in Internal Medicine, Surgery and OB/GYN.
- Out of country- Aga Khan Hospital, Nairobi, Kenya,
East Africa
Senior House Officer in General Surgery
Education:
- Medical: Kastuba Medial College, Karnataka, India
- M.B.B.S. Mysore University.
- Premedical: Wilson College, Bombay, India.
- B.Sc., Bombay University.
- F.R.C.S., Royal College of Surgeons, Dublin,
Ireland.
- Passed special examination for professional and
linguistic ability to practice in the United Kingdom.
- Passed V.Q.E. in September 1980 in London,
England.
- Passed FLEX in Indiana State, June 1982.
- Board Certified in Internal Medicine in September
1985, #103055.
- Board Certified in Cardiology in November 1987.
Hospital Affiliation:
- St. Joseph Mercy Oakland, Pontiac, Michigan.
- William Beaumont Hospital, Royal Oak, Michigan.
- North Oakland Medical Center, Pontiac, Michigan.
Professional Societies:
- American College of Cardiology.
- American Medical Association.
- Oakland County Medical Society.
- Michigan State Medical Society.
Practice History:
- 01/01/2000 - present- Cardiology and Vascular
Associates, P.C.
- 1986 - 2000- Private practice in Clinical and
Interventional Cardiology at St. Joseph Mercy Oakland
and William Beaumont Hospital. Over the last ten(10)
years, have done over 5,000 coronary interventions,
including atherectomies, laser angioplasties, coronary
stents, etc. Also have extensive experience in
coronary angiography.
Funded Research
Project Experience:
- 1994 - 1995- Sub-investigator. Grant from COR
Therapeutics, Inc., for a study entitled: "A
Randomized, Double-Blind Efficacy and Safety
Evaluation of Two Dosing Regimens of Integrilin Versus
Placebo for Reducing the Complications of Coronary
Angioplasty". (IMPACT II study)
- 1996 - 1997- Sub-investigator. Grant from G.D.
Searle & Co., for a study entitled: "Safety and
Efficacy of Xemilofiban Hydrochloride Administration
to Patients with Stable or Unstable Angina or
Hospitalized for a Recent Myocardial Infarction and
Have Completed Coronary Revascularization". (ORBIT
study)
- 1997 - 1999- Sub-investigator. Grant from G.D.
Searle & Co., for a study entitled: "Safety and
Efficacy of Xemilofiban Hydrochloride Administration
to Patients Undergoing Coronary Angioplasty or Stent
Placement". (EXCITE study)
- 1998 - 2000- Co-investigator. Grant from Advanced
Cardiovascular Systems, Inc. and Lilly Research
Laboratories, for a study entitled: "A Randomized
Comparison of the ACS Multi-Link Coronary Stent System
with or without Abciximab Versus PTCA with or without
Abciximab in the Treatment of Patients with Acute
Myocardial Infarction". (Cadillac study)
- 1999 - Present- Participating Physician. Grant
from MEDCO Research, Inc., for the study entitled: "A
Randomized, Double-Blind, Placebo-Controlled,
Multicenter Trial to Evaluate the Efficacy and Safety
of Adenosine (Pallacor, Adenosine Injection) as an
Adjunct to Reperfusion Therapy (Thrombolysis or
Mechanical Reperfusion) in the Treatment of Acute
Anterolateral Myocardial Infarction." (AMISTAD study)
- 1999 - Present- Participating Physician. Grant
from Novartis Pharmaceuticals, for the study entitled:
"Multinational, Multicenter, Double-Blind, Randomized,
Active Controlled, Parallel Group Study Comparing the
Efficacy and Safety of Long-Term Treatment With
Valsartan, Captopril, and Their Combination in
High-Risk Patients After Myocardial Infection".
(VALIANT study)
| |
|
|
|
